foxo4-dri senolytic animal model 2023 2024

foxo4-dri senolytic animal model 2023 2024 Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Senolytics: from pharmacological inhibitors to

Name: foxo4-dri senolytic animal model 2023 2024 Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Senolytics: from pharmacological inhibitors to
Brand: astonvaughan.co.uk
SKU: 6847316844
Price: 28.63 USD
Availability: InStock
Rating: 4.369 (24 reviews)

Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytic therapeutics: An emerging treatment modality for osteoarthritis ScienceDirect

SKU: 6847316844 · From astonvaughan.co.uk

4.4

USD28.63 USD70.63

Pay in 4 interest-free payments of $7.16 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Memberships Stay Up-to-Date with IntraVenous Solutions Frequently Asked Questions IV therapy, short for intravenous therapy, delivers vitamins, minerals, and nutrients directly to the bloodstream

The hepatocyte growth factor (HGF)/c-MET pathway is upregulated in PC and mediates the interaction between cancer cells and stromal pancreatic stellate cells (PSCs)